Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Hair follicles prevent NK cell attacks to avoid hair loss.

Dengue virus can infect human hair follicle cells and may cause hair loss.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Somatostatin may help protect hair follicles from immune attacks.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

People with Down syndrome have higher rates of certain immune-related conditions and need special medical attention.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Type 1 Diabetes prevents hair growth by causing cell death in hair follicles.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

ILC1 cells contribute to hair loss in alopecia areata.